Used in the development of pharmaceutical agents, particularly as a potential kinase inhibitor targeting specific enzymes involved in inflammatory diseases, cytokine signaling pathways, and certain cancers. It has shown promise in drug discovery for conditions like rheumatoid arthritis and psoriasis.

In vitro and animal model studies demonstrate its activity in reducing the production of pro-inflammatory cytokines such as TNF-α and IL-6, which helps mitigate inflammation and tissue damage in target organs. The compound exhibits high specificity for molecular targets, potentially leading to fewer side effects compared to other drugs in the same class.

Its structure supports binding to ATP sites in kinases, enhancing its value in medicinal chemistry. It is also under investigation for dermatological treatments due to its stability and selectivity in topical formulations. Currently in early-stage research, efforts focus on optimizing absorption, distribution, pharmacokinetics, and safety prior to human trials.